血管支架市场:按技术、按产品、按输送模式、按材料、按最终用户、按地区 - 预测至 2029 年
市场调查报告书
商品编码
1556885

血管支架市场:按技术、按产品、按输送模式、按材料、按最终用户、按地区 - 预测至 2029 年

Vascular Stent Market by Technology (Dug-eluting, Covered), Product (Coronary, Peripheral (Carotid, Renal)), MOD (Balloon-expandable, Self-expanding), Material (Metal (PtCr,CoCr), Polymer), End User (Hospitals, Cardiac Center) - Global Forecast to 2029

出版日期: | 出版商: MarketsandMarkets | 英文 427 Pages | 订单完成后即时交付

价格

全球血管支架市场规模预计将从2024年的114亿美元增加至2029年的156亿美元,2024年至2029年复合年增长率为6.5%。

市场成长是由领先公司的收购增加和微创手术的日益采用所推动的。然而,治疗血管疾病的替代治疗方法的可用性正在影响市场的成长。此外,血管支架领域的产品召回和缺陷是限制市场成长的主要因素。

调查范围
调查年份 2021-2029
基准年 2023年
预测期 2024-2029
考虑单位 金额(十亿美元)
按细分市场 按技术、产品、交付模式、材料、最终用户、地区
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东/非洲

依材质分为金属材料和高分子材料。聚合物链段又分为生物分解性和非生物分解聚合物。在这两种聚合物中,生物分解性聚合物领域预计将在 2023 年见证血管支架市场的最高成长。生物分解性聚合物预计将在血管支架市场显着扩张,因为它们作为药物具有广泛的应用前景。这些聚合物对于涂药支架(DES) 平台至关重要,可确保抗增殖药物的最佳释放,并实现最佳的 DES 性能。与永久性聚合物相比,生物分解性聚合物可以抑制动脉壁的慢性发炎,从而降低晚期再血管再阻塞和支架内血栓症的风险。临床实验表明,生物分解性聚合物 DES 平台在植入后 1 年内的表现与永久性聚合物 DES 平台相似,长期追踪显示支架血栓症率令人放心。患者安全性和疗效的改善正在推动市场扩张。

依产品划分,血管支架市场分为冠状动脉支架、週边支架及EVAR血管支架。 2023年,外周支架将在其中占据很大份额。在预测期内,由于週边血管疾病盛行率不断上升,特别是在人口老化中,週边血管支架市场预计将出现显着增长。根据美国心臟协会 2023 年 6 月的数据,全球有 2 亿人,美国约有 1,200 万人患有周边血管疾病 (PAD)。这种不断上升的盛行率凸显了对有效替代治疗(例如周边支架)的需求。此外,生物分解性聚合物支架的开发提供了一种更以患者为中心、侵入性较小且易于使用的替代方案,进一步提高了其采用率和市场扩张。

该报告研究了全球血管支架市场,包括按技术、产品、输送模式、材料、最终用户、地区和参与市场的公司概况分類的趋势。

目录

第一章 简介

第二章调查方法

第三章执行摘要

第 4 章重要考察

第五章市场概况

  • 介绍
  • 市场动态
  • 产业动态
  • 技术分析
  • 波特五力分析
  • 监管状况
  • 专利分析
  • 贸易分析
  • 价格分析
  • 重大会议及活动
  • 主要相关人员和采购标准
  • 未满足的需求
  • 最终用户的期望
  • 生成式人工智慧对血管支架市场的影响
  • 生态系分析
  • 案例研究分析
  • 供应链分析
  • 影响客户业务的趋势/干扰
  • 投资金筹措场景
  • 邻近市场分析

第六章血管支架市场(依技术分)

  • 介绍
  • 药物释放型支架
  • 裸金属支架
  • 覆膜支架
  • 生物可吸收支架

第七章血管支架市场(分产品)

  • 介绍
  • 冠状动脉支架
  • 外周支架
  • EVAR血管支架

第八章血管支架市场(以输送方式)

  • 介绍
  • 球囊扩张型支架
  • 自动扩张型支架

第九章血管支架市场(依材料分)

  • 介绍
  • 金属材质
  • 高分子材料

第10章血管支架市场(依最终用户)

  • 介绍
  • 医院
  • 心臟中心

第十一章血管支架市场(分地区)

  • 介绍
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第十二章竞争格局

  • 概述
  • 主要参与企业的策略/秘密
  • 收益分析
  • 市场占有率分析
  • 企业评估矩阵:主要参与企业,2023
  • 企业评估矩阵:Start-Ups/小型企业,2023 年
  • 公司评价及财务指标
  • 品牌/产品比较
  • 竞争场景

第十三章 公司简介

  • 主要参与企业
    • MEDTRONIC PLC
    • ABBOTT LABORATORIES
    • BOSTON SCIENTIFIC CORPORATION
    • B. BRAUN SE
    • TERUMO CORPORATION
    • BIOTRONIK SE & CO. KG.
    • SHANGHAI MICROPORT MEDICAL(GROUP)CO., LTD.
    • MERIL LIFE SCIENCES PVT. LTD.
    • SAHAJANAND MEDICAL TECHNOLOGIES LIMITED
    • BECTON, DICKINSON AND COMPANY
    • WL GORE & ASSOCIATES, INC.
    • CORDIS CORPORATION(SUBSIDIARY OF HELLMAN & FRIEDMAN LLC)
    • ARTIVION, INC.
    • STRYKER CORPORATION
    • LIFETECH SCIENTIFIC CORPORATION
    • TRANSLUMINA
    • LEPU MEDICAL TECHNOLOGY(BEIJING)CO., LTD.
    • ENDOLOGIX LLC.
    • BIOSENSORS INTERNATIONAL GROUP, LTD.
  • 其他公司
    • COOK MEDICAL
    • INSITU TECHNOLOGIES INC.
    • IVASCULAR
    • ORBUSNEICH MEDICAL GROUP HOLDINGS LIMITED
    • ALVIMEDICA
    • ELIXIR MEDICAL

第十四章附录

Product Code: MD 5228

The global vascular stent market is projected to reach USD 15.6 billion by 2029 from USD 11.4 billion in 2024, at a CAGR of 6.5% from 2024 to 2029. The growth of the market is driven by increase in acquisitions by major players, increase in adoption of minimally invasive procedures. However, availability of alternative treatment methods to treat vascular disease, is impacting the growth of the market. Moreover, the product recalls and failures in the field of vascular stent are a major factor restraining the market growth.

Scope of the Report
Years Considered for the Study2021-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD Billion)
SegmentsBy Technology, Product, Mode of Delivery, Material, and End User
Regions coveredNorth America, Europe, Asia Pacific, Latin America, the Middle East, and Africa

"Polymer segment to witness the significant growth during the forecast period."

Based on material, the segment is divided into metallic material, and polymer material. The polymer segment is further divided into biodegradable polymers and non-biodegradable polymers. In 2023, among these two polymers, the biodegradable polymer segment to witness the highest growth in vascular stent market. Because of their prospective medicinal uses, biodegradable polymers are expected to witness significant expansion in the vascular stent market. These polymers, which are essential for drug-eluting stent (DES) platforms, guarantee the antiproliferative medications' optimum release, leading to the best possible DES performance. Compared to permanent polymers, biodegradable polymers can reduce chronic inflammation of the arterial wall, hence reducing the risk of late restenosis and stent thrombosis. Clinical experiments have demonstrated that biodegradable polymer DES platforms function similarly to permanent polymer DES platforms during the first year of implantation, with longer-term follow-ups revealing encouragingly lower rates of stent thrombosis. The promise to increase patient safety and efficacy is what motivates their planned market expansion.

"Peripheral segment accounted for the significant growth in the vascular stent market during the forecast period."

Based on product, the vascular stent market is segmented into coronary stents, peripheral stents, and EVAR stent grafts. Among these in 2023, peripheral stents accounted for significant share. Throughout the projected period, peripheral stents are anticipated to have substantial growth in the vascular stent market, driven by the increased prevalence of peripheral vascular illnesses, especially in the aging population. The American Heart Association revealed in June 2023 that 200 million people worldwide and approximately 12 million Americans suffer with peripheral vascular disease (PAD). This rising prevalence highlights the need for efficient treatment alternatives such as Stents for the periphery. Additionally, developments in biodegradable polymer stents provide a more patient-centered, minimally invasive approachable substitute, increasing their uptake and market expansion even more.

"APAC is estimated to register the highest CAGR during the forecast period."

In this report, the vascular stent market is segmented into five major regional segments, namely, North America, Europe, Asia Pacific, Latin America and Middle East and Africa. During the forecast period, the Asia Pacific region is anticipated to experience the largest growth in the vascular stent market by material, mainly because of the increasingly aging population that is causing an increase in the frequency of cardiovascular illnesses. As of June 2022, the population of Asia and the Pacific is aging at a rate faster than any other region in the world, with 630 million people in the region making up 60% of the world's senior population, according to the Economic and Social Commission for Asia and the Pacific. By 2050, it is anticipated that this number would increase to 1.3 billion, greatly increasing the need for vascular stents to treat age-related cardiovascular diseases and propelling market expansion.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%)
  • By Designation: C-level (30%), Director-level (20%), and Others (50%)
  • By Region: North America (35%), Europe (24%), Asia Pacific (25%), RoW (16%)

List of Companies Profiled in the Report

    • Medtronic Plc (Ireland)
    • Abbott Laboratories (US)
    • Boston Scientific Corporation (US)
    • B Braun SE (Germany)
    • Terumo Corporation (Japan)
    • Biotronik SE & Co.KG (Germany)
    • Shanghai Microport Medical (Group) Co., Ltd (China)
    • Meril Life Science Pvt. Ltd (India)
    • Sahajanan Medical Technologies Limited (India)
    • Becton, Dickinson, and Company (US)
    • W.L. Gore & Associates, Inc (US)
    • Cordis Corporation (US)
    • Artivion Inc (US)
    • Stryker Corporation (US)
    • LifeTech Scientific Corporation (China)
    • Translumina (Germany)
    • Lepu Medical Technology (Beijing) Co., Ltd (China)
    • Endologix LLC. (US)
    • Biosensors International Group, Ltd (Singapore)
    • Cook Medical (US)
    • Insitu Technologies Inc (US)
    • iVascular (Spain)
    • OrbusNeich Medical Group Holdings Limited (China)
    • Alvimedica (Turkey).
    • Elixir Medical (US)

Research Coverage

This report studies the vascular stent market based on product, procedure, technology, application, end user and region. The report also analyses factors (such as drivers, restraints, opportunities and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total vascular stent market. The report forecasts the revenue of the market segments with respect to five major regions.

Reasons to Buy the Report

This report also includes.

  • Analysis of key drivers (rising incidence of vascular diseases and growth in number of angioplasty procedures, advancements in stent technology and materials, increase in adoption of minimally invasive procedures),restraints (Availability of alternative treatment methods for vascular diseases, stringent regulations for product approval, product failures and recalls), challenges (High risk of complications, declining cost of stent), opportunities (Development of bioresorbable vascular scaffold stent, emerging markets to offer high-growth opportunities for market participants, increase in aging population) contributing the growth of the vascular stent market.
  • Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new software launches in the vascular stent market.
  • Market Development: Comprehensive information on the lucrative emerging markets, technology, product, mode of delivery, material, end-user and region.
  • Market Diversification: Exhaustive information about the growing geographies, recent developments, investments in the vascular stent market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global vascular stent market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 MARKET STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
  • 2.4 MARKET RANKING ANALYSIS
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
    • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.6.2 SCOPE-RELATED LIMITATIONS
  • 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 VASCULAR STENTS MARKET OVERVIEW
  • 4.2 NORTH AMERICA: VASCULAR STENTS MARKET, BY PRODUCT
  • 4.3 GEOGRAPHIC SNAPSHOT OF VASCULAR STENTS MARKET
  • 4.4 VASCULAR STENTS MARKET: REGIONAL MIX, 2024-2029 (USD MILLION)

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing incidence of vascular diseases and subsequent rise in angioplasty procedures
      • 5.2.1.2 Technological advancements in stents
      • 5.2.1.3 Growing preference for minimally invasive surgeries
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Availability of open surgical procedures to hinder market growth
      • 5.2.2.2 Stringent regulatory guidelines for product approval
      • 5.2.2.3 Product failures and recalls
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Development of bioresorbable vascular scaffold stents
      • 5.2.3.2 High growth potential of emerging markets
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Complications associated with stenting procedures
      • 5.2.4.2 Declining cost of stents
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 COMBINATION THERAPIES
    • 5.3.2 PERSONALIZED MEDICINE
    • 5.3.3 EXPANDING APPLICATIONS
  • 5.4 TECHNOLOGY ANALYSIS
    • 5.4.1 KEY TECHNOLOGIES
      • 5.4.1.1 3D printing
      • 5.4.1.2 Electrospinning
      • 5.4.1.3 Balloon-expandable stents
    • 5.4.2 COMPLEMENTARY TECHNOLOGIES
      • 5.4.2.1 Element simulation technology
      • 5.4.2.2 Stereolithography (SLA) technology
      • 5.4.2.3 Laser-cutting technology
    • 5.4.3 ADJACENT TECHNOLOGIES
      • 5.4.3.1 Continuous sinusoid technology
      • 5.4.3.2 Micro-injection molding technology
      • 5.4.3.3 Imaging technology
  • 5.5 PORTER'S FIVE FORCE ANALYSIS
    • 5.5.1 INTENSITY OF COMPETITIVE RIVALRY
    • 5.5.2 BARGAINING POWER OF SUPPLIERS
    • 5.5.3 BARGAINING POWER OF BUYERS
    • 5.5.4 THREAT OF SUBSTITUTES
    • 5.5.5 THREAT OF NEW ENTRANTS
  • 5.6 REGULATORY LANDSCAPE
    • 5.6.1 REGULATORY ANALYSIS
      • 5.6.1.1 North America
        • 5.6.1.1.1 US
        • 5.6.1.1.2 Canada
      • 5.6.1.2 Europe
      • 5.6.1.3 Asia Pacific
        • 5.6.1.3.1 Japan
        • 5.6.1.3.2 China
      • 5.6.1.4 Latin America
      • 5.6.1.5 Middle East & Africa
    • 5.6.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.7 PATENT ANALYSIS
    • 5.7.1 PATENT PUBLICATION TRENDS IN VASCULAR STENTS MARKET
    • 5.7.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.8 TRADE ANALYSIS
    • 5.8.1 TRADE ANALYSIS FOR VASCULAR STENTS
  • 5.9 PRICING ANALYSIS
  • 5.10 KEY CONFERENCES & EVENTS
  • 5.11 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.11.2 BUYING CRITERIA
  • 5.12 UNMET NEEDS
  • 5.13 END-USER EXPECTATIONS
  • 5.14 IMPACT OF GENERATIVE AI ON VASCULAR STENTS MARKET
  • 5.15 ECOSYSTEM ANALYSIS
  • 5.16 CASE STUDY ANALYSIS
    • 5.16.1 CASE STUDY 1: UTILIZATION OF GORE VIABAHN VBX BALLOON-EXPANDABLE STENTS FOR ANGIOGRAPHY PROCEDURE
    • 5.16.2 CASE STUDY 2: SUCCESSFUL TREATMENT OF PATIENT WITH SEVERE CAROTID ARTERY STENOSIS
    • 5.16.3 CASE STUDY 3: W.L. GORE UTILIZED VBX BALLOON-EXPANDABLE STENT FOR ILIAC ARTERY STENOSIS TREATMENT
  • 5.17 SUPPLY CHAIN ANALYSIS
  • 5.18 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.19 INVESTMENT & FUNDING SCENARIO
  • 5.20 ADJACENT MARKET ANALYSIS
    • 5.20.1 INTERVENTIONAL CARDIOLOGY DEVICES MARKET

6 VASCULAR STENT MARKET, BY TECHNOLOGY

  • 6.1 INTRODUCTION
  • 6.2 DRUG-ELUTING STENTS
    • 6.2.1 LONG-TERM BENEFITS ASSOCIATED WITH DRUG-ELUTING STENTS TO DRIVE MARKET
  • 6.3 BARE METAL STENTS
    • 6.3.1 COST-EFFICIENT BENEFITS TO FUEL UPTAKE
  • 6.4 COVERED STENTS
    • 6.4.1 UTILIZATION IN ENDOVASCULAR REPAIR AND VASCULAR LESIONS TO DRIVE MARKET
  • 6.5 BIOABSORBABLE STENTS
    • 6.5.1 ABILITY TO MINIMIZE COMPLICATIONS ASSOCIATED WITH PERMANENT DEVICES TO SUPPORT MARKET GROWTH

7 VASCULAR STENTS MARKET, BY PRODUCT

  • 7.1 INTRODUCTION
  • 7.2 CORONARY STENTS
    • 7.2.1 INCREASING PREVALENCE OF CORONARY ARTERY DISEASE TO PROPEL MARKET
  • 7.3 PERIPHERAL STENTS
    • 7.3.1 CAROTID ARTERY STENTS
      • 7.3.1.1 Rapid recovery time and lower risk of myocardial ischemia to boost demand
    • 7.3.2 FEMORAL ARTERY STENTS
      • 7.3.2.1 Minimal incisions and shorter recovery time to fuel market
    • 7.3.3 RENAL ARTERY STENTS
      • 7.3.3.1 Rising incidence of hypertension and FMD to support market growth
    • 7.3.4 ILIAC ARTERY STENTS
      • 7.3.4.1 Increasing prevalence of atherosclerosis to fuel uptake
    • 7.3.5 OTHER PERIPHERAL STENTS
  • 7.4 EVAR STENT GRAFTS
    • 7.4.1 ABDOMINAL AORTIC ANEURYSM STENT GRAFTS
      • 7.4.1.1 Rising incidence of AAA cases to drive market
    • 7.4.2 THORACIC AORTIC ANEURYSM STENT GRAFTS
      • 7.4.2.1 Rising prevalence of renal artery stenosis to support market growth

8 VASCULAR STENTS MARKET, BY MODE OF DELIVERY

  • 8.1 INTRODUCTION
  • 8.2 BALLOON-EXPANDABLE STENTS
    • 8.2.1 ABILITY TO TREAT CORONARY VESSEL DAMAGE TO DRIVE MARKET
  • 8.3 SELF-EXPANDING STENTS
    • 8.3.1 HIGH UPTAKE IN ABDOMINAL & THORACIC EVAR PROCEDURES TO PROPEL MARKET

9 VASCULAR STENTS MARKET, BY MATERIAL

  • 9.1 INTRODUCTION
  • 9.2 METALLIC MATERIALS
    • 9.2.1 COBALT CHROMIUM
      • 9.2.1.1 Biocompatibility properties to boost demand
    • 9.2.2 PLATINUM CHROMIUM
      • 9.2.2.1 Enhanced visibility and superior radial strength to support market growth
    • 9.2.3 NICKEL TITANIUM
      • 9.2.3.1 Growing adoption of MIS procedures to boost demand
    • 9.2.4 STAINLESS STEEL
      • 9.2.4.1 High reliability and cost-efficiency to boost uptake
  • 9.3 POLYMERIC MATERIALS
    • 9.3.1 BIODEGRADABLE POLYMERS
      • 9.3.1.1 Advantages offered by biodegradable polymers to drive market
    • 9.3.2 NON-BIODEGRADABLE POLYMERS
      • 9.3.2.1 Inert alternative to potential inflammatory responses to support market growth

10 VASCULAR STENTS MARKET, BY END USER

  • 10.1 INTRODUCTION
  • 10.2 HOSPITALS
    • 10.2.1 RISING NUMBER OF ANGIOPLASTY PROCEDURES TO FUEL MARKET
  • 10.3 CARDIAC CENTERS
    • 10.3.1 INCREASING CASES OF STROKE TO DRIVE MARKET

11 VASCULAR STENTS MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
    • 11.2.2 US
      • 11.2.2.1 Supportive regulatory policies for cardiovascular product commercialization to fuel uptake
    • 11.2.3 CANADA
      • 11.2.3.1 Rising incidence of peripheral artery disease to drive market
  • 11.3 EUROPE
    • 11.3.1 EUROPE: MACROECONOMIC OUTLOOK
    • 11.3.2 GERMANY
      • 11.3.2.1 Rising uptake of angioplasty procedures to fuel market
    • 11.3.3 UK
      • 11.3.3.1 Increasing incidence of acute coronary syndrome to propel market
    • 11.3.4 FRANCE
      • 11.3.4.1 Rising incidence of chronic diseases to drive market
    • 11.3.5 ITALY
      • 11.3.5.1 Rising cases of atherosclerotic CVD to support market growth
    • 11.3.6 SPAIN
      • 11.3.6.1 Increasing prevalence of obesity to boost demand
    • 11.3.7 REST OF EUROPE
  • 11.4 ASIA PACIFIC
    • 11.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
    • 11.4.2 CHINA
      • 11.4.2.1 Growing demand for peripheral artery stents to drive market
    • 11.4.3 JAPAN
      • 11.4.3.1 Increasing preference for PCI surgeries to drive market
    • 11.4.4 INDIA
      • 11.4.4.1 Improvements in healthcare policies for affordable medical devices to propel market
    • 11.4.5 AUSTRALIA
      • 11.4.5.1 Rising hospitalization rates due to CAD cases to drive market
    • 11.4.6 SOUTH KOREA
      • 11.4.6.1 Rising incidence of diabetes to boost demand
    • 11.4.7 REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    • 11.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK
    • 11.5.2 BRAZIL
      • 11.5.2.1 Growing demand for advanced medical equipment to drive market
    • 11.5.3 MEXICO
      • 11.5.3.1 Increasing imports of medical devices to fuel market
    • 11.5.4 REST OF LATIN AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
    • 11.6.2 GCC COUNTRIES
      • 11.6.2.1 Increasing prevalence of hypertension to drive market
    • 11.6.3 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN VASCULAR STENTS MARKET
  • 12.3 REVENUE ANALYSIS
  • 12.4 MARKET SHARE ANALYSIS
    • 12.4.1 RANKING OF KEY MARKET PLAYERS
  • 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 12.5.1 STARS
    • 12.5.2 EMERGING LEADERS
    • 12.5.3 PERVASIVE PLAYERS
    • 12.5.4 PARTICIPANTS
    • 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 12.5.5.1 Company footprint
      • 12.5.5.2 Technology footprint
      • 12.5.5.3 Product footprint
      • 12.5.5.4 Mode of delivery footprint
      • 12.5.5.5 Material footprint
      • 12.5.5.6 End-user footprint
      • 12.5.5.7 Region footprint
  • 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 12.6.1 PROGRESSIVE COMPANIES
    • 12.6.2 RESPONSIVE COMPANIES
    • 12.6.3 DYNAMIC COMPANIES
    • 12.6.4 STARTING BLOCKS
    • 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 12.7 COMPANY VALUATION & FINANCIAL METRICS
    • 12.7.1 FINANCIAL METRICS
    • 12.7.2 COMPANY VALUATION
  • 12.8 BRAND/PRODUCT COMPARISON
  • 12.9 COMPETITIVE SCENARIO
    • 12.9.1 PRODUCT LAUNCHES & APPROVALS
    • 12.9.2 DEALS
    • 12.9.3 OTHER DEVELOPMENTS

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
    • 13.1.1 MEDTRONIC PLC
      • 13.1.1.1 Business overview
      • 13.1.1.2 Products offered
      • 13.1.1.3 Recent developments
        • 13.1.1.3.1 Product approvals
      • 13.1.1.4 MnM view
        • 13.1.1.4.1 Key strengths
        • 13.1.1.4.2 Strategic choices
        • 13.1.1.4.3 Weaknesses & competitive threats
    • 13.1.2 ABBOTT LABORATORIES
      • 13.1.2.1 Business overview
      • 13.1.2.2 Products offered
      • 13.1.2.3 Recent developments
        • 13.1.2.3.1 Deals
      • 13.1.2.4 MnM view
        • 13.1.2.4.1 Key strengths
        • 13.1.2.4.2 Strategic choices
        • 13.1.2.4.3 Weaknesses & competitive threats
    • 13.1.3 BOSTON SCIENTIFIC CORPORATION
      • 13.1.3.1 Business overview
      • 13.1.3.2 Products offered
      • 13.1.3.3 Recent developments
        • 13.1.3.3.1 Deals
      • 13.1.3.4 MnM view
        • 13.1.3.4.1 Key strengths
        • 13.1.3.4.2 Strategic choices
        • 13.1.3.4.3 Weaknesses & competitive threats
    • 13.1.4 B. BRAUN SE
      • 13.1.4.1 Business overview
      • 13.1.4.2 Products offered
      • 13.1.4.3 MnM view
        • 13.1.4.3.1 Key strengths
        • 13.1.4.3.2 Strategic choices
        • 13.1.4.3.3 Weaknesses & competitive threats
    • 13.1.5 TERUMO CORPORATION
      • 13.1.5.1 Business overview
      • 13.1.5.2 Products offered
      • 13.1.5.3 Recent developments
        • 13.1.5.3.1 Product approvals
      • 13.1.5.4 MnM view
        • 13.1.5.4.1 Key strengths
        • 13.1.5.4.2 Strategic choices
        • 13.1.5.4.3 Weaknesses & competitive threats
    • 13.1.6 BIOTRONIK SE & CO. KG.
      • 13.1.6.1 Business overview
      • 13.1.6.2 Products offered
    • 13.1.7 SHANGHAI MICROPORT MEDICAL (GROUP) CO., LTD.
      • 13.1.7.1 Business overview
      • 13.1.7.2 Products offered
      • 13.1.7.3 Recent developments
        • 13.1.7.3.1 Product launches & approvals
    • 13.1.8 MERIL LIFE SCIENCES PVT. LTD.
      • 13.1.8.1 Business overview
      • 13.1.8.2 Products offered
    • 13.1.9 SAHAJANAND MEDICAL TECHNOLOGIES LIMITED
      • 13.1.9.1 Business overview
      • 13.1.9.2 Products offered
    • 13.1.10 BECTON, DICKINSON AND COMPANY
      • 13.1.10.1 Business overview
      • 13.1.10.2 Products offered
    • 13.1.11 W. L. GORE & ASSOCIATES, INC.
      • 13.1.11.1 Business overview
      • 13.1.11.2 Products offered
      • 13.1.11.3 Recent developments
        • 13.1.11.3.1 Product launches & approvals
    • 13.1.12 CORDIS CORPORATION (SUBSIDIARY OF HELLMAN & FRIEDMAN LLC)
      • 13.1.12.1 Business overview
      • 13.1.12.2 Products offered
      • 13.1.12.3 Recent developments
        • 13.1.12.3.1 Product approvals
        • 13.1.12.3.2 Other developments
    • 13.1.13 ARTIVION, INC.
      • 13.1.13.1 Business overview
      • 13.1.13.2 Products offered
      • 13.1.13.3 Recent developments
        • 13.1.13.3.1 Other developments
    • 13.1.14 STRYKER CORPORATION
      • 13.1.14.1 Business overview
      • 13.1.14.2 Products offered
    • 13.1.15 LIFETECH SCIENTIFIC CORPORATION
      • 13.1.15.1 Business overview
      • 13.1.15.2 Products offered
    • 13.1.16 TRANSLUMINA
      • 13.1.16.1 Business overview
      • 13.1.16.2 Products offered
    • 13.1.17 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
      • 13.1.17.1 Business overview
      • 13.1.17.2 Products offered.
    • 13.1.18 ENDOLOGIX LLC.
      • 13.1.18.1 Business overview
      • 13.1.18.2 Products offered
    • 13.1.19 BIOSENSORS INTERNATIONAL GROUP, LTD.
      • 13.1.19.1 Business overview
      • 13.1.19.2 Products offered
      • 13.1.19.3 Recent developments
        • 13.1.19.3.1 Product approvals
  • 13.2 OTHER PLAYERS
    • 13.2.1 COOK MEDICAL
    • 13.2.2 INSITU TECHNOLOGIES INC.
    • 13.2.3 IVASCULAR
    • 13.2.4 ORBUSNEICH MEDICAL GROUP HOLDINGS LIMITED
    • 13.2.5 ALVIMEDICA
    • 13.2.6 ELIXIR MEDICAL

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 CURRENCY CONVERSION RATES
  • TABLE 2 VASCULAR STENTS MARKET: STUDY ASSUMPTIONS
  • TABLE 3 VASCULAR STENTS MARKET: RISK ASSESSMENT ANALYSIS
  • TABLE 4 PORTER'S FIVE FORCES ANALYSIS
  • TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 8 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 LIST OF PATENTS IN VASCULAR STENTS MARKET, 2014-2024
  • TABLE 11 IMPORT DATA FOR VASCULAR STENTS, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 12 EXPORT DATA FOR VASCULAR STENTS, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 13 VASCULAR STENTS MARKET: AVERAGE SELLING PRICE
  • TABLE 14 REGIONAL AVERAGE PRICING ANALYSIS OF VASCULAR STENTS, 2023
  • TABLE 15 VASCULAR STENTS MARKET: KEY CONFERENCES & EVENTS, 2024-2025
  • TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VASCULAR STENTS
  • TABLE 17 KEY BUYING CRITERIA FOR VASCULAR STENTS, BY PRODUCT
  • TABLE 18 VASCULAR STENTS MARKET: UNMET NEEDS
  • TABLE 19 VASCULAR STENTS MARKET: END-USER EXPECTATIONS
  • TABLE 20 VASCULAR STENTS MARKET: IMPACT OF GENERATIVE AI
  • TABLE 21 VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
  • TABLE 22 VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024-2029 (USD MILLION)
  • TABLE 23 DRUG-ELUTING STENTS OFFERED BY KEY PLAYERS
  • TABLE 24 DRUG-ELUTING STENTS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 25 DRUG-ELUTING STENTS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 26 BARE METAL STENTS OFFERED BY KEY PLAYERS
  • TABLE 27 BARE METAL STENTS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 28 BARE METAL STENTS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 29 COVERED STENTS OFFERED BY KEY PLAYERS
  • TABLE 30 COVERED STENTS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 31 COVERED STENTS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 32 BIOABSORBABLE STENTS OFFERED BY KEY PLAYERS
  • TABLE 33 BIOABSORBABLE STENTS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 34 BIOABSORBABLE STENTS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 35 VASCULAR STENTS MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
  • TABLE 36 VASCULAR STENTS MARKET, BY PRODUCT, 2024-2029 (USD MILLION)
  • TABLE 37 CORONARY STENTS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 38 CORONARY STENTS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 39 PERIPHERAL STENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 40 PERIPHERAL STENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 41 PERIPHERAL STENTS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 42 PERIPHERAL STENTS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 43 CAROTID ARTERY STENTS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 44 CAROTID ARTERY STENTS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 45 FEMORAL ARTERY STENTS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 46 FEMORAL ARTERY STENTS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 47 RENAL ARTERY STENTS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 48 RENAL ARTERY STENTS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 49 ILIAC ARTERY STENTS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 50 ILIAC ARTERY STENTS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 51 OTHER PERIPHERAL STENTS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 52 OTHER PERIPHERAL STENTS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 53 EVAR STENT GRAFTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 54 EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 55 ABDOMINAL AORTIC ANEURYSM STENT GRAFTS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 56 ABDOMINAL AORTIC ANEURYSM STENT GRAFTS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 57 THORACIC AORTIC ANEURYSM STENT GRAFTS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 58 THORACIC AORTIC ANEURYSM STENT GRAFTS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 59 VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021-2023 (USD MILLION)
  • TABLE 60 VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024-2029 (USD MILLION)
  • TABLE 61 BALLOON-EXPANDABLE STENTS OFFERED BY KEY PLAYERS
  • TABLE 62 BALLOON-EXPANDABLE STENTS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 63 BALLOON-EXPANDABLE STENTS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 64 SELF-EXPANDING STENTS PROVIDED BY KEY PLAYERS
  • TABLE 65 SELF-EXPANDING STENTS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 66 SELF-EXPANDING STENTS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 67 VASCULAR STENTS MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
  • TABLE 68 VASCULAR STENTS MARKET, BY MATERIAL, 2024-2029 (USD MILLION)
  • TABLE 69 VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 70 VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 71 VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 72 VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 73 VASCULAR STENTS MARKET FOR COBALT CHROMIUM, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 74 VASCULAR STENTS MARKET FOR COBALT CHROMIUM, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 75 VASCULAR STENTS MARKET FOR PLATINUM CHROMIUM, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 76 VASCULAR STENTS MARKET FOR PLATINUM CHROMIUM, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 77 VASCULAR STENTS MARKET FOR NICKEL TITANIUM, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 78 VASCULAR STENTS MARKET FOR NICKEL TITANIUM, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 79 VASCULAR STENTS MARKET FOR STAINLESS STEEL, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 80 VASCULAR STENTS MARKET FOR STAINLESS STEEL, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 81 VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 82 VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 83 VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 84 VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 85 VASCULAR STENTS MARKET FOR BIODEGRADABLE POLYMERS, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 86 VASCULAR STENTS MARKET FOR BIODEGRADABLE POLYMERS, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 87 VASCULAR STENTS MARKET FOR NON-BIODEGRADABLE POLYMERS, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 88 VASCULAR STENTS MARKET FOR NON-BIODEGRADABLE POLYMERS, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 89 VASCULAR STENTS MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 90 VASCULAR STENTS MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 91 VASCULAR STENTS MARKET FOR HOSPITALS, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 92 VASCULAR STENTS MARKET FOR HOSPITALS, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 93 VASCULAR STENTS MARKET FOR CARDIAC CENTERS, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 94 VASCULAR STENTS MARKET FOR CARDIAC CENTERS, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 95 VASCULAR STENTS MARKET, BY REGION, 2021-2023 (USD MILLION)
  • TABLE 96 VASCULAR STENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 97 VASCULAR STENTS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 98 VASCULAR STENTS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 99 NORTH AMERICA: VASCULAR STENTS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 100 NORTH AMERICA: VASCULAR STENTS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 101 NORTH AMERICA: VASCULAR STENTS MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
  • TABLE 102 NORTH AMERICA: VASCULAR STENTS MARKET, BY PRODUCT, 2024-2029 (USD MILLION)
  • TABLE 103 NORTH AMERICA: PERIPHERAL STENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 104 NORTH AMERICA: PERIPHERAL STENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 105 NORTH AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 106 NORTH AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 107 NORTH AMERICA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
  • TABLE 108 NORTH AMERICA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024-2029 (USD MILLION)
  • TABLE 109 NORTH AMERICA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021-2029 (THOUSAND UNITS)
  • TABLE 110 NORTH AMERICA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021-2023 (USD MILLION)
  • TABLE 111 NORTH AMERICA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024-2029 (USD MILLION)
  • TABLE 112 NORTH AMERICA: VASCULAR STENTS MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
  • TABLE 113 NORTH AMERICA: VASCULAR STENTS MARKET, BY MATERIAL, 2024-2029 (USD MILLION)
  • TABLE 114 NORTH AMERICA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 115 NORTH AMERICA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 116 NORTH AMERICA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 117 NORTH AMERICA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 118 NORTH AMERICA: VASCULAR STENTS MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 119 NORTH AMERICA: VASCULAR STENTS MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 120 US: KEY MACROINDICATORS
  • TABLE 121 US: VASCULAR STENTS MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
  • TABLE 122 US: VASCULAR STENTS MARKET, BY PRODUCT, 2024-2029 (USD MILLION)
  • TABLE 123 US: PERIPHERAL STENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 124 US: PERIPHERAL STENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 125 US: EVAR STENT GRAFTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 126 US: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 127 US: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
  • TABLE 128 US: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024-2029 (USD MILLION)
  • TABLE 129 US: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021-2023 (USD MILLION)
  • TABLE 130 US: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024-2029 (USD MILLION)
  • TABLE 131 US: VASCULAR STENTS MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
  • TABLE 132 US: VASCULAR STENTS MARKET, BY MATERIAL, 2024-2029 (USD MILLION)
  • TABLE 133 US: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 134 US: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 135 US: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 136 US: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 137 US: VASCULAR STENTS MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 138 US: VASCULAR STENTS MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 139 CANADA: KEY MACROINDICATORS
  • TABLE 140 CANADA: VASCULAR STENTS MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
  • TABLE 141 CANADA: VASCULAR STENTS MARKET, BY PRODUCT, 2024-2029 (USD MILLION)
  • TABLE 142 CANADA: PERIPHERAL STENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 143 CANADA: PERIPHERAL STENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 144 CANADA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 145 CANADA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 146 CANADA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
  • TABLE 147 CANADA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024-2029 (USD MILLION)
  • TABLE 148 CANADA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021-2023 (USD MILLION)
  • TABLE 149 CANADA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024-2029 (USD MILLION)
  • TABLE 150 CANADA: VASCULAR STENTS MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
  • TABLE 151 CANADA: VASCULAR STENTS MARKET, BY MATERIAL, 2024-2029 (USD MILLION)
  • TABLE 152 CANADA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 153 CANADA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 154 CANADA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 155 CANADA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 156 CANADA: VASCULAR STENTS MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 157 CANADA: VASCULAR STENTS MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 158 EUROPE: VASCULAR STENTS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 159 EUROPE: VASCULAR STENTS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 160 EUROPE: VASCULAR STENTS MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
  • TABLE 161 EUROPE: VASCULAR STENTS MARKET, BY PRODUCT, 2024-2029 (USD MILLION)
  • TABLE 162 EUROPE: PERIPHERAL STENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 163 PERIPHERAL STENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 164 EUROPE: EVAR STENT GRAFTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 165 EUROPE: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 166 EUROPE: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
  • TABLE 167 EUROPE: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024-2029 (USD MILLION)
  • TABLE 168 EUROPE: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021-2029 (THOUSAND UNITS)
  • TABLE 169 EUROPE: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021-2023 (USD MILLION)
  • TABLE 170 EUROPE: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024-2029 (USD MILLION)
  • TABLE 171 EUROPE: VASCULAR STENTS MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
  • TABLE 172 EUROPE: VASCULAR STENTS MARKET, BY MATERIAL, 2024-2029 (USD MILLION)
  • TABLE 173 EUROPE: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 174 EUROPE: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 175 EUROPE: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 176 EUROPE: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 177 EUROPE: VASCULAR STENTS MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 178 EUROPE: VASCULAR STENTS MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 179 GERMANY: KEY MACROINDICATORS
  • TABLE 180 GERMANY: VASCULAR STENTS MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
  • TABLE 181 GERMANY: VASCULAR STENTS MARKET, BY PRODUCT, 2024-2029 (USD MILLION)
  • TABLE 182 GERMANY: PERIPHERAL STENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 183 GERMANY: PERIPHERAL STENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 184 GERMANY: EVAR STENT GRAFTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 185 GERMANY: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 186 GERMANY: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
  • TABLE 187 GERMANY: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024-2029 (USD MILLION)
  • TABLE 188 GERMANY: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021-2023 (USD MILLION)
  • TABLE 189 GERMANY: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024-2029 (USD MILLION)
  • TABLE 190 GERMANY: VASCULAR STENTS MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
  • TABLE 191 GERMANY: VASCULAR STENTS MARKET, BY MATERIAL, 2024-2029 (USD MILLION)
  • TABLE 192 GERMANY: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 193 GERMANY: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 194 GERMANY: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 195 GERMANY: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 196 GERMANY: VASCULAR STENTS MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 197 GERMANY: VASCULAR STENTS MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 198 UK: KEY MACROINDICATORS
  • TABLE 199 UK: VASCULAR STENTS MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
  • TABLE 200 UK: VASCULAR STENTS MARKET, BY PRODUCT, 2024-2029 (USD MILLION)
  • TABLE 201 UK: PERIPHERAL STENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 202 UK: PERIPHERAL STENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 203 UK: EVAR STENT GRAFTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 204 UK: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 205 UK: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
  • TABLE 206 UK: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024-2029 (USD MILLION)
  • TABLE 207 UK: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021-2023 (USD MILLION)
  • TABLE 208 UK: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024-2029 (USD MILLION)
  • TABLE 209 UK: VASCULAR STENTS MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
  • TABLE 210 UK: VASCULAR STENTS MARKET, BY MATERIAL, 2024-2029 (USD MILLION)
  • TABLE 211 UK: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 212 UK: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 213 UK: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 214 UK: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 215 UK: VASCULAR STENTS MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 216 UK: VASCULAR STENTS MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 217 FRANCE: KEY MACROINDICATORS
  • TABLE 218 FRANCE: VASCULAR STENTS MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
  • TABLE 219 FRANCE: VASCULAR STENTS MARKET, BY PRODUCT, 2024-2029 (USD MILLION)
  • TABLE 220 FRANCE: PERIPHERAL STENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 221 FRANCE: PERIPHERAL STENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 222 FRANCE: EVAR STENT GRAFTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 223 FRANCE: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 224 FRANCE: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
  • TABLE 225 FRANCE: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024-2029 (USD MILLION)
  • TABLE 226 FRANCE: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021-2023 (USD MILLION)
  • TABLE 227 FRANCE: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024-2029 (USD MILLION)
  • TABLE 228 FRANCE: VASCULAR STENTS MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
  • TABLE 229 FRANCE: VASCULAR STENTS MARKET, BY MATERIAL, 2024-2029 (USD MILLION)
  • TABLE 230 FRANCE: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 231 FRANCE: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 232 FRANCE: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 233 FRANCE: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 234 FRANCE: VASCULAR STENTS MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 235 FRANCE: VASCULAR STENTS MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 236 ITALY: KEY MACROINDICATORS
  • TABLE 237 ITALY: VASCULAR STENTS MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
  • TABLE 238 ITALY: VASCULAR STENTS MARKET, BY PRODUCT, 2024-2029 (USD MILLION)
  • TABLE 239 ITALY: PERIPHERAL STENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 240 ITALY: PERIPHERAL STENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 241 ITALY: EVAR STENT GRAFTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 242 ITALY: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 243 ITALY: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
  • TABLE 244 ITALY: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024-2029 (USD MILLION)
  • TABLE 245 ITALY: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021-2023 (USD MILLION)
  • TABLE 246 ITALY: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024-2029 (USD MILLION)
  • TABLE 247 ITALY: VASCULAR STENTS MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
  • TABLE 248 ITALY: VASCULAR STENTS MARKET, BY MATERIAL, 2024-2029 (USD MILLION)
  • TABLE 249 ITALY: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 250 ITALY: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 251 ITALY: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 252 ITALY: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 253 ITALY: VASCULAR STENTS MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 254 ITALY: VASCULAR STENTS MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 255 SPAIN: KEY MACROINDICATORS
  • TABLE 256 SPAIN: VASCULAR STENTS MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
  • TABLE 257 SPAIN: VASCULAR STENTS MARKET, BY PRODUCT, 2024-2029 (USD MILLION)
  • TABLE 258 SPAIN: PERIPHERAL STENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 259 SPAIN: PERIPHERAL STENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 260 SPAIN: EVAR STENT GRAFTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 261 SPAIN: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 262 SPAIN: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
  • TABLE 263 SPAIN: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024-2029 (USD MILLION)
  • TABLE 264 SPAIN: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021-2023 (USD MILLION)
  • TABLE 265 SPAIN: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024-2029 (USD MILLION)
  • TABLE 266 SPAIN: VASCULAR STENTS MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
  • TABLE 267 SPAIN: VASCULAR STENTS MARKET, BY MATERIAL, 2024-2029 (USD MILLION)
  • TABLE 268 SPAIN: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 269 SPAIN: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 270 SPAIN: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 271 SPAIN: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 272 SPAIN: VASCULAR STENTS MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 273 SPAIN: VASCULAR STENTS MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 274 REST OF EUROPE: VASCULAR STENTS MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
  • TABLE 275 REST OF EUROPE: VASCULAR STENTS MARKET, BY PRODUCT, 2024-2029 (USD MILLION)
  • TABLE 276 REST OF EUROPE: PERIPHERAL STENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 277 REST OF EUROPE: PERIPHERAL STENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 278 REST OF EUROPE: EVAR STENT GRAFTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 279 REST OF EUROPE: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 280 REST OF EUROPE: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
  • TABLE 281 REST OF EUROPE: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024-2029 (USD MILLION)
  • TABLE 282 REST OF EUROPE: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021-2023 (USD MILLION)
  • TABLE 283 REST OF EUROPE: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024-2029 (USD MILLION)
  • TABLE 284 REST OF EUROPE: VASCULAR STENTS MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
  • TABLE 285 REST OF EUROPE: VASCULAR STENTS MARKET, BY MATERIAL, 2024-2029 (USD MILLION)
  • TABLE 286 REST OF EUROPE: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 287 REST OF EUROPE: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 288 REST OF EUROPE: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 289 REST OF EUROPE: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 290 REST OF EUROPE: VASCULAR STENTS MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 291 REST OF EUROPE: VASCULAR STENTS MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 292 ASIA PACIFIC: VASCULAR STENTS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 293 ASIA PACIFIC: VASCULAR STENTS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 294 ASIA PACIFIC: VASCULAR STENTS MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
  • TABLE 295 ASIA PACIFIC: VASCULAR STENTS MARKET, BY PRODUCT, 2024-2029 (USD MILLION)
  • TABLE 296 ASIA PACIFIC: PERIPHERAL STENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 297 ASIA PACIFIC: PERIPHERAL STENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 298 ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 299 ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 300 ASIA PACIFIC: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
  • TABLE 301 ASIA PACIFIC: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024-2029 (USD MILLION)
  • TABLE 302 ASIA PACIFIC: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021-2029 (THOUSAND UNITS)
  • TABLE 303 ASIA PACIFIC: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021-2023 (USD MILLION)
  • TABLE 304 ASIA PACIFIC: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024-2029 (USD MILLION)
  • TABLE 305 ASIA PACIFIC: VASCULAR STENTS MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
  • TABLE 306 ASIA PACIFIC: VASCULAR STENTS MARKET, BY MATERIAL, 2024-2029 (USD MILLION)
  • TABLE 307 ASIA PACIFIC: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 308 ASIA PACIFIC: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 309 ASIA PACIFIC: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 310 ASIA PACIFIC: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 311 ASIA PACIFIC: VASCULAR STENTS MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 312 ASIA PACIFIC: VASCULAR STENTS MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 313 CHINA: KEY MACROINDICATORS
  • TABLE 314 CHINA: VASCULAR STENTS MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
  • TABLE 315 CHINA: VASCULAR STENTS MARKET, BY PRODUCT, 2024-2029 (USD MILLION)
  • TABLE 316 CHINA: PERIPHERAL STENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 317 CHINA: PERIPHERAL STENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 318 CHINA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 319 CHINA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 320 CHINA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
  • TABLE 321 CHINA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024-2029 (USD MILLION)
  • TABLE 322 CHINA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021-2023 (USD MILLION)
  • TABLE 323 CHINA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024-2029 (USD MILLION)
  • TABLE 324 CHINA: VASCULAR STENTS MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
  • TABLE 325 CHINA: VASCULAR STENTS MARKET, BY MATERIAL, 2024-2029 (USD MILLION)
  • TABLE 326 CHINA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 327 CHINA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 328 CHINA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 329 CHINA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 330 CHINA: VASCULAR STENTS MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 331 CHINA: VASCULAR STENTS MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 332 JAPAN: KEY MACROINDICATORS
  • TABLE 333 JAPAN: VASCULAR STENTS MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
  • TABLE 334 JAPAN: VASCULAR STENTS MARKET, BY PRODUCT, 2024-2029 (USD MILLION)
  • TABLE 335 JAPAN: PERIPHERAL STENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 336 JAPAN: PERIPHERAL STENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 337 JAPAN: EVAR STENT GRAFTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 338 JAPAN: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 339 JAPAN: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
  • TABLE 340 JAPAN: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024-2029 (USD MILLION)
  • TABLE 341 JAPAN: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021-2023 (USD MILLION)
  • TABLE 342 JAPAN: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024-2029 (USD MILLION)
  • TABLE 343 JAPAN: VASCULAR STENTS MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
  • TABLE 344 JAPAN: VASCULAR STENTS MARKET, BY MATERIAL, 2024-2029 (USD MILLION)
  • TABLE 345 JAPAN: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 346 JAPAN: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 347 JAPAN: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 348 JAPAN: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 349 JAPAN: VASCULAR STENTS MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 350 JAPAN: VASCULAR STENTS MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 351 INDIA: KEY MACROINDICATORS
  • TABLE 352 INDIA: VASCULAR STENTS MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
  • TABLE 353 INDIA: VASCULAR STENTS MARKET, BY PRODUCT, 2024-2029 (USD MILLION)
  • TABLE 354 INDIA: PERIPHERAL STENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 355 INDIA: PERIPHERAL STENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 356 INDIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 357 INDIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 358 INDIA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
  • TABLE 359 INDIA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024-2029 (USD MILLION)
  • TABLE 360 INDIA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021-2023 (USD MILLION)
  • TABLE 361 INDIA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024-2029 (USD MILLION)
  • TABLE 362 INDIA: VASCULAR STENTS MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
  • TABLE 363 INDIA: VASCULAR STENTS MARKET, BY MATERIAL, 2024-2029 (USD MILLION)
  • TABLE 364 INDIA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 365 INDIA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 366 INDIA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 367 INDIA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 368 INDIA: VASCULAR STENTS MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 369 INDIA: VASCULAR STENTS MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 370 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 371 AUSTRALIA: VASCULAR STENTS MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
  • TABLE 372 AUSTRALIA: VASCULAR STENTS MARKET, BY PRODUCT, 2024-2029 (USD MILLION)
  • TABLE 373 AUSTRALIA: PERIPHERAL STENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 374 AUSTRALIA: PERIPHERAL STENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 375 AUSTRALIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 376 AUSTRALIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 377 AUSTRALIA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
  • TABLE 378 AUSTRALIA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024-2029 (USD MILLION)
  • TABLE 379 AUSTRALIA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021-2023 (USD MILLION)
  • TABLE 380 AUSTRALIA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024-2029 (USD MILLION)
  • TABLE 381 AUSTRALIA: VASCULAR STENTS MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
  • TABLE 382 AUSTRALIA: VASCULAR STENTS MARKET, BY MATERIAL, 2024-2029 (USD MILLION)
  • TABLE 383 AUSTRALIA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 384 AUSTRALIA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 385 AUSTRALIA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 386 AUSTRALIA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 387 AUSTRALIA: VASCULAR STENTS MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 388 AUSTRALIA: VASCULAR STENTS MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 389 SOUTH KOREA: KEY MACROINDICATORS
  • TABLE 390 SOUTH KOREA: VASCULAR STENTS MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
  • TABLE 391 SOUTH KOREA: VASCULAR STENTS MARKET, BY PRODUCT, 2024-2029 (USD MILLION)
  • TABLE 392 SOUTH KOREA: PERIPHERAL STENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 393 SOUTH KOREA: PERIPHERAL STENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 394 SOUTH KOREA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 395 SOUTH KOREA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 396 SOUTH KOREA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
  • TABLE 397 SOUTH KOREA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024-2029 (USD MILLION)
  • TABLE 398 SOUTH KOREA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021-2023 (USD MILLION)
  • TABLE 399 SOUTH KOREA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024-2029 (USD MILLION)
  • TABLE 400 SOUTH KOREA: VASCULAR STENTS MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
  • TABLE 401 SOUTH KOREA: VASCULAR STENTS MARKET, BY MATERIAL, 2024-2029 (USD MILLION)
  • TABLE 402 SOUTH KOREA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 403 SOUTH KOREA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 404 SOUTH KOREA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 405 SOUTH KOREA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 406 SOUTH KOREA: VASCULAR STENTS MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 407 SOUTH KOREA: VASCULAR STENTS MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 408 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
  • TABLE 409 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET, BY PRODUCT, 2024-2029 (USD MILLION)
  • TABLE 410 REST OF ASIA PACIFIC: PERIPHERAL STENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 411 REST OF ASIA PACIFIC: PERIPHERAL STENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 412 REST OF ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 413 REST OF ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 414 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
  • TABLE 415 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024-2029 (USD MILLION)
  • TABLE 416 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021-2023 (USD MILLION)
  • TABLE 417 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024-2029 (USD MILLION)
  • TABLE 418 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
  • TABLE 419 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET, BY MATERIAL, 2024-2029 (USD MILLION)
  • TABLE 420 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 421 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 422 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 423 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 424 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 425 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 426 LATIN AMERICA: VASCULAR STENTS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 427 LATIN AMERICA: VASCULAR STENTS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 428 LATIN AMERICA: VASCULAR STENTS MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
  • TABLE 429 LATIN AMERICA: VASCULAR STENTS MARKET, BY PRODUCT, 2024-2029 (USD MILLION)
  • TABLE 430 LATIN AMERICA: PERIPHERAL STENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 431 LATIN AMERICA: PERIPHERAL STENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 432 LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 433 LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 434 LATIN AMERICA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
  • TABLE 435 LATIN AMERICA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024-2029 (USD MILLION)
  • TABLE 436 LATIN AMERICA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021-2029 (THOUSAND UNITS)
  • TABLE 437 LATIN AMERICA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021-2023 (USD MILLION)
  • TABLE 438 LATIN AMERICA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024-2029 (USD MILLION)
  • TABLE 439 LATIN AMERICA: VASCULAR STENTS MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
  • TABLE 440 LATIN AMERICA: VASCULAR STENTS MARKET, BY MATERIAL, 2024-2029 (USD MILLION)
  • TABLE 441 LATIN AMERICA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 442 LATIN AMERICA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 443 LATIN AMERICA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 444 LATIN AMERICA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 445 LATIN AMERICA: VASCULAR STENTS MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 446 LATIN AMERICA: VASCULAR STENTS MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 447 BRAZIL: KEY MACROINDICATORS
  • TABLE 448 BRAZIL: VASCULAR STENTS MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
  • TABLE 449 BRAZIL: VASCULAR STENTS MARKET, BY PRODUCT, 2024-2029 (USD MILLION)
  • TABLE 450 BRAZIL: PERIPHERAL STENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 451 BRAZIL: PERIPHERAL STENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 452 BRAZIL: EVAR STENT GRAFTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 453 BRAZIL: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 454 BRAZIL: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
  • TABLE 455 BRAZIL: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024-2029 (USD MILLION)
  • TABLE 456 BRAZIL: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021-2023 (USD MILLION)
  • TABLE 457 BRAZIL: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024-2029 (USD MILLION)
  • TABLE 458 BRAZIL: VASCULAR STENTS MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
  • TABLE 459 BRAZIL: VASCULAR STENTS MARKET, BY MATERIAL, 2024-2029 (USD MILLION)
  • TABLE 460 BRAZIL: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 461 BRAZIL: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 462 BRAZIL: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 463 BRAZIL: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 464 BRAZIL: VASCULAR STENTS MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 465 BRAZIL: VASCULAR STENTS MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 466 MEXICO: KEY MACROINDICATORS
  • TABLE 467 MEXICO: VASCULAR STENTS MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
  • TABLE 468 MEXICO: VASCULAR STENTS MARKET, BY PRODUCT, 2024-2029 (USD MILLION)
  • TABLE 469 MEXICO: PERIPHERAL STENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 470 MEXICO: PERIPHERAL STENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 471 MEXICO: EVAR STENT GRAFTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 472 MEXICO: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 473 MEXICO: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
  • TABLE 474 MEXICO: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024-2029 (USD MILLION)
  • TABLE 475 MEXICO: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021-2023 (USD MILLION)
  • TABLE 476 MEXICO: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024-2029 (USD MILLION)
  • TABLE 477 MEXICO: VASCULAR STENTS MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
  • TABLE 478 MEXICO: VASCULAR STENTS MARKET, BY MATERIAL, 2024-2029 (USD MILLION)
  • TABLE 479 MEXICO: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 480 MEXICO: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 481 MEXICO: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 482 MEXICO: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 483 MEXICO: VASCULAR STENTS MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 484 MEXICO: VASCULAR STENTS MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 485 REST OF LATIN AMERICA: VASCULAR STENTS MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
  • TABLE 486 REST OF LATIN AMERICA: VASCULAR STENTS MARKET, BY PRODUCT, 2024-2029 (USD MILLION)
  • TABLE 487 REST OF LATIN AMERICA: PERIPHERAL STENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 488 REST OF LATIN AMERICA: PERIPHERAL STENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 489 REST OF LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 490 REST OF LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 491 REST OF LATIN AMERICA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
  • TABLE 492 REST OF LATIN AMERICA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024-2029 (USD MILLION)
  • TABLE 493 REST OF LATIN AMERICA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021-2023 (USD MILLION)
  • TABLE 494 REST OF LATIN AMERICA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024-2029 (USD MILLION)
  • TABLE 495 REST OF LATIN AMERICA: VASCULAR STENTS MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
  • TABLE 496 REST OF LATIN AMERICA: VASCULAR STENTS MARKET, BY MATERIAL, 2024-2029 (USD MILLION)
  • TABLE 497 REST OF LATIN AMERICA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 498 REST OF LATIN AMERICA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 499 REST OF LATIN AMERICA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 500 REST OF LATIN AMERICA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 501 REST OF LATIN AMERICA: VASCULAR STENTS MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 502 REST OF LATIN AMERICA: VASCULAR STENTS MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 503 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY REGION, 2021-2023 (USD MILLION)
  • TABLE 504 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 505 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
  • TABLE 506 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY PRODUCT, 2024-2029 (USD MILLION)
  • TABLE 507 MIDDLE EAST & AFRICA: PERIPHERAL STENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 508 MIDDLE EAST & AFRICA: PERIPHERAL STENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 509 MIDDLE EAST & AFRICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 510 MIDDLE EAST & AFRICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 511 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
  • TABLE 512 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024-2029 (USD MILLION)
  • TABLE 513 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021-2029 (THOUSAND UNITS)
  • TABLE 514 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021-2023 (USD MILLION)
  • TABLE 515 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024-2029 (USD MILLION)
  • TABLE 516 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
  • TABLE 517 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY MATERIAL, 2024-2029 (USD MILLION)
  • TABLE 518 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 519 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 520 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 521 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 522 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 523 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 524 GCC COUNTRIES: VASCULAR STENTS MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
  • TABLE 525 GCC COUNTRIES: VASCULAR STENTS MARKET, BY PRODUCT, 2024-2029 (USD MILLION)
  • TABLE 526 GCC COUNTRIES: PERIPHERAL STENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 527 GCC COUNTRIES: PERIPHERAL STENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 528 GCC COUNTRIES: EVAR STENT GRAFTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 529 GCC COUNTRIES: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 530 GCC COUNTRIES: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
  • TABLE 531 GCC COUNTRIES: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024-2029 (USD MILLION)
  • TABLE 532 GCC COUNTRIES: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021-2023 (USD MILLION)
  • TABLE 533 GCC COUNTRIES: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024-2029 (USD MILLION)
  • TABLE 534 GCC COUNTRIES: VASCULAR STENTS MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
  • TABLE 535 GCC COUNTRIES: VASCULAR STENTS MARKET, BY MATERIAL, 2024-2029 (USD MILLION)
  • TABLE 536 GCC COUNTRIES: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 537 GCC COUNTRIES: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 538 GCC COUNTRIES: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 539 GCC COUNTRIES: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 540 GCC COUNTRIES: VASCULAR STENTS MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 541 GCC COUNTRIES: VASCULAR STENTS MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 542 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
  • TABLE 543 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY PRODUCT, 2024-2029 (USD MILLION)
  • TABLE 544 REST OF MIDDLE EAST & AFRICA: PERIPHERAL STENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 545 REST OF MIDDLE EAST & AFRICA: PERIPHERAL STENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 546 REST OF MIDDLE EAST & AFRICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 547 REST OF MIDDLE EAST & AFRICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 548 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
  • TABLE 549 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024-2029 (USD MILLION)
  • TABLE 550 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021-2023 (USD MILLION)
  • TABLE 551 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024-2029 (USD MILLION)
  • TABLE 552 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
  • TABLE 553 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY MATERIAL, 2024-2029 (USD MILLION)
  • TABLE 554 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 555 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 556 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 557 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 558 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 559 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 560 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
  • TABLE 561 VASCULAR STENTS MARKET: DEGREE OF COMPETITION
  • TABLE 562 VASCULAR STENTS MARKET: TECHNOLOGY FOOTPRINT
  • TABLE 563 VASCULAR STENTS MARKET: PRODUCT FOOTPRINT
  • TABLE 564 VASCULAR STENTS MARKET: MODE OF DELIVERY FOOTPRINT
  • TABLE 565 VASCULAR STENTS MARKET: MATERIAL FOOTPRINT
  • TABLE 566 VASCULAR STENTS MARKET: END-USER FOOTPRINT
  • TABLE 567 VASCULAR STENTS MARKET: REGION FOOTPRINT
  • TABLE 568 VASCULAR STENTS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 569 VASCULAR STENTS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY PRODUCT
  • TABLE 570 VASCULAR STENTS MARKET: PRODUCT L & APPROVALS, JANUARY 2021-JULY 2024
  • TABLE 571 VASCULAR STENTS MARKET: DEALS, JANUARY 2021-JULY 2024
  • TABLE 572 VASCULAR STENTS MARKET: OTHER DEVELOPMENTS, JANUARY 2021-JULY 2024
  • TABLE 573 MEDTRONIC PLC: COMPANY OVERVIEW
  • TABLE 574 MEDTRONIC PLC: PRODUCTS OFFERED
  • TABLE 575 MEDTRONIC PLC: PRODUCT APPROVALS, JANUARY 2021-JULY 2024
  • TABLE 576 ABBOTT LABORATORIES: COMPANY OVERVIEW
  • TABLE 577 ABBOTT LABORATORIES: PRODUCTS OFFERED
  • TABLE 578 ABBOTT LABORATORIES: DEALS, JANUARY 2021-JULY 2024
  • TABLE 579 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 580 BOSTON SCIENTIFIC CORPORATION.: PRODUCTS OFFERED
  • TABLE 581 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2021-JULY 2024
  • TABLE 582 B. BRAUN SE: COMPANY OVERVIEW
  • TABLE 583 B. BRAUN SE: PRODUCTS OFFERED
  • TABLE 584 TERUMO CORPORATION: COMPANY OVERVIEW
  • TABLE 585 TERUMO CORPORATION: PRODUCTS OFFERED
  • TABLE 586 TERUMO CORPORATION: PRODUCT APPROVALS, JANUARY 2021-JULY 2024
  • TABLE 587 BIOTRONIK SE & CO. KG: COMPANY OVERVIEW
  • TABLE 588 BIOTRONIK SE & CO.KG.: PRODUCTS OFFERED
  • TABLE 589 SHANGHAI MICROPORT MEDICAL (GROUP) CO., LTD.: COMPANY OVERVIEW
  • TABLE 590 SHANGHAI MICROPORT MEDICAL (GROUP) CO., LTD.: PRODUCTS OFFERED
  • TABLE 591 SHANGHAI MICROPORT MEDICAL (GROUP) CO., LTD: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JULY 2024
  • TABLE 592 MERIL LIFE SCIENCES PVT. LTD.: COMPANY OVERVIEW
  • TABLE 593 MERIL LIFE SCIENCES PVT. LTD.: PRODUCTS OFFERED
  • TABLE 594 SAHAJANAND MEDICAL TECHNOLOGIES LIMITED: COMPANY OVERVIEW
  • TABLE 595 SAHAJANAND MEDICAL TECHNOLOGIES LIMITED: PRODUCTS OFFERED
  • TABLE 596 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
  • TABLE 597 BECTON, DICKINSON AND COMPANY.: PRODUCTS OFFERED
  • TABLE 598 W. L. GORE & ASSOCIATES, INC: COMPANY OVERVIEW
  • TABLE 599 W. L. GORE & ASSOCIATES, INC.: PRODUCTS OFFERED
  • TABLE 600 W. L. GORE & ASSOCIATES, INC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JULY 2024
  • TABLE 601 CORDIS CORPORATION: COMPANY OVERVIEW
  • TABLE 602 CORDIS CORPORATION: PRODUCTS OFFERED
  • TABLE 603 CORDIS CORPORATION: PRODUCT APPROVALS, JANUARY 2021-JULY 2024
  • TABLE 604 CORDIS CORPORATION: OTHER DEVELOPMENTS, JANUARY 2021-JULY 2024
  • TABLE 605 ARTIVION, INC.: COMPANY OVERVIEW
  • TABLE 606 ARTIVION, INC.: PRODUCTS OFFERED
  • TABLE 607 ARTIVION, INC.: OTHER DEVELOPMENTS, JANUARY 2021-JULY 2024
  • TABLE 608 STRYKER CORPORATION.: COMPANY OVERVIEW
  • TABLE 609 STRYKER CORPORATION.: PRODUCTS OFFERED
  • TABLE 610 LIFETECH SCIENTIFIC CORPORATION.: COMPANY OVERVIEW
  • TABLE 611 LIFETECH SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 612 TRANSLUMINA: COMPANY OVERVIEW
  • TABLE 613 TRANSLUMINA: PRODUCTS OFFERED
  • TABLE 614 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY OVERVIEW
  • TABLE 615 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: PRODUCTS OFFERED
  • TABLE 616 ENDOLOGIX LLC.: COMPANY OVERVIEW
  • TABLE 617 ENDOLOGIX LLC.PRODUCTS OFFERED
  • TABLE 618 BIOSENSORS INTERNATIONAL GROUP, LTD.: COMPANY OVERVIEW
  • TABLE 619 BIOSENSORS INTERNATIONAL GROUP, LTD.: PRODUCTS OFFERED
  • TABLE 620 BIOSENSORS INTERNATIONAL GROUP, LTD.: PRODUCT APPROVALS, JANUARY 2021-JULY 2024

List of Figures

  • FIGURE 1 RESEARCH DESIGN
  • FIGURE 2 PRIMARY SOURCES
  • FIGURE 3 PRIMARY BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
  • FIGURE 5 TOP-DOWN APPROACH
  • FIGURE 6 MARKET SIZE ESTIMATION: DEMAND-SIDE ASSESSMENT
  • FIGURE 7 IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024-2029)
  • FIGURE 8 VASCULAR STENTS MARKET: CAGR PROJECTIONS
  • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • FIGURE 10 VASCULAR STENTS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 11 VASCULAR STENTS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 PERIPHERAL STENTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 EVAR STENT GRAFTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 VASCULAR STENTS MARKET, BY MATERIAL, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 VASCULAR STENTS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 17 VASCULAR STENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 18 RISING PREVALENCE OF VASCULAR DISEASES AND SUBSEQUENT RISE IN ANGIOPLASTY PROCEDURES TO PROPEL MARKET
  • FIGURE 19 CORONARY STENTS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN US (2023)
  • FIGURE 20 EMERGING MARKETS TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 21 ASIA PACIFIC REGION TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 22 VASCULAR STENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 23 NUMBER OF PATENTS PUBLISHED (JANUARY 2014-MARCH 2024)
  • FIGURE 24 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR VASCULAR STENTS PATENTS (JANUARY 2014-JULY 2024)
  • FIGURE 25 TOP APPLICANT COUNTRIES/REGIONS FOR VASCULAR STENTS (JANUARY 2014- JULY 2024)
  • FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VASCULAR STENTS
  • FIGURE 27 KEY BUYING CRITERIA FOR VASCULAR STENTS
  • FIGURE 28 VASCULAR STENTS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 29 VASCULAR STENTS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 30 REVENUE SHIFT FOR VASCULAR STENTS MARKET
  • FIGURE 31 VASCULAR STENTS MARKET: INVESTMENT AND FUNDING SCENARIO (2018-2022)
  • FIGURE 32 INTERVENTIONAL CARDIOLOGY DEVICES: MARKET OVERVIEW
  • FIGURE 33 NORTH AMERICA: VASCULAR STENTS MARKET SNAPSHOT
  • FIGURE 34 ASIA PACIFIC: VASCULAR STENTS MARKET SNAPSHOT
  • FIGURE 35 REVENUE ANALYSIS OF KEY PLAYERS IN VASCULAR STENTS MARKET (2021-2023)
  • FIGURE 36 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VASCULAR STENTS MARKET (2023)
  • FIGURE 37 RANKING OF KEY PLAYERS IN VASCULAR STENTS MARKET, 2023
  • FIGURE 38 VASCULAR STENTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 39 VASCULAR STENTS MARKET: COMPANY FOOTPRINT
  • FIGURE 40 VASCULAR STENTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 41 EV/EBITDA OF KEY VENDORS
  • FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 43 VASCULAR STENTS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 44 MEDTRONIC PLC: COMPANY SNAPSHOT (2023)
  • FIGURE 45 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2023)
  • FIGURE 46 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 47 B. BRAUN SE: COMPANY SNAPSHOT (2023)
  • FIGURE 48 TERUMO CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 49 SHANGHAI MICROPORT MEDICAL (GROUP) CO., LTD.: COMPANY SNAPSHOT (2023)
  • FIGURE 50 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2023)
  • FIGURE 51 ARTIVION, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 52 STRYKER CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 53 LIFETECH SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023)